|

PD-1/CTLA-4 inhibitor (Aiparolitoworixureli injection) Clinical Trials

1 actively recruiting trial

No change since May 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Sir Run Run Shaw Hospital1

Indications

Other1 trial

Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.